Avvisto Therapeutics

Avvisto Therapeutics is a privately held biotechnology company dedicated to the discovery and development of novel precision oncology treatments. Headquartered in San Diego, the company focuses on leveraging synthetic lethality and DNA Damage Response (DDR) mechanisms to target hard-to-treat cancers. Avvisto utilizes a proprietary drug discovery platform to design highly selective small molecule inhibitors aimed at overcoming therapeutic resistance. Led by a team of seasoned biopharma executives, the company is advancing a pipeline of preclinical programs toward clinical validation. Their approach integrates deep genomic insights with medicinal chemistry to deliver transformative medicines for patients with high unmet needs.